CompletedNCT00032955
Buprenorphine-naloxone or clonidine for opioid detoxification
About this title
Read the official source — NCT00032955Medication studyAges 15+United StatesAddiction
Understand this study
Who was this study for?
Listed age limits: from 15 years.
- Listed locations
- Rancho Mirage and 5 more locationsSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateFebruary 2001
- Recruitment status
- Completed
- Enrollment listed in the registry
- 163
- Sponsor
- University of California, Los Angeles
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- Over 15 Years
- Official registry ID
- NCT00032955
- Official title
Show the full official title
Buprenorphine/Naloxone Versus Clonidine for Inpatient Opiate Detoxification
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Rancho Mirage · Orlando · Pinellas Park
3 more locations
- Detroit
- New York
- Columbus
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of California, Los Angeles, a university.
Did this study involve medication?
Yes. The study involved medication, including Buprenorphine/naloxone.
Who was this study for?
Listed age limits: from 15 years.
